Mus vs Slovakia: HIV-positive TB patients on ART (antiretroviral therapy)
Mus
100.0%
in 2024
Slovakia
100.0%
in 2021
Mus rank
1st
Slovakia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Mus
- Slovakia
How they compare
Mus currently reports 100.0% against 100.0% in Slovakia, a difference of 0.0%.
The two have swapped places 2 times across 7 shared years of data; in 2005 it was Slovakia ahead.
Mus ranks 1st and Slovakia ranks 1st of 2 regions.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.5% | 100.0% | 39.5% | Slovakia |
| 2010s | 76.3% | 91.7% | 15.3% | Slovakia |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Mus or Slovakia?
- Mus, at 100.0% against 100.0% in Slovakia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Mus and Slovakia?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Slovakia?
- 7 years are reported by both, from 2005 to 2021.
- How do Mus and Slovakia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Mus ranks 1st and Slovakia ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.